The Fight Continues: Battling the COVID Evolution

While it feels like we’re back to a pre-pandemic sense of normal, COVID continues to be an evolving virus, mutating into new variants that threaten the fragile stability of our current status quo. As the number of Omicron subvariants continue to mult...

Advancing Diverse Representation in Clinical Trials and Research

HealthVerity offerings support the call for action by the Committee on Improving Representation of Women and Underrepresented Minorities in Clinical Trials and Research.

HealthVerity supports the call for action by the Committee on Improving Representation of Women and Underrepresented Minorities in Clinical Trials and Research on the critical issue of diverse representation.

The committee’s recent report spotlights gaps and opportunities to improve today’s approaches to clinical trial research.  HealthVerity is committed to doing our part to help ensure the study of future therapies are inclusive of diverse patient populations.

  • HealthVerity Provider Diversity Index
    We’re excited to announce that we’ve refreshed our HealthVerity Provider Diversity Index which allows clinical trial sponsors and CROs to easily find healthcare providers (including specialty providers) who treat a racially diverse group of patients in any US zip code. Gaining visibility to a physician’s patient demographics will give sponsors an opportunity to better direct their recruitment efforts towards enrolling a well-rounded patient cohort that is more representative of the actual patient population that the therapy aims to treat.
  • Maternal Outcomes Masterset
    HealthVerity also recently launched the innovative Maternal Outcomes Masterset (MOM), a groundbreaking approach for generating novel insights regarding the impact of healthcare interventions on pregnant mothers and their babies.  These are crucial populations who are not typically eligible for traditional clinical trials.  MOM was designed to enable researchers to leverage longitudinal clinical data to follow mothers and their babies in tandem throughout their pregnancy journey. The mom-baby linked data preserves critical data elements such as race, ethnicity, maternal age, birth events and pregnancy outcomes to enable novel pregnancy studies, all in a HIPAA-compliant manner.

To learn more about our work on the Provider Diversity Index and Maternal Outcomes Masterset to support diverse representation in clinical trials and research, please reach out to us.

Related Post:

The Fight Continues: Battling the COVID Evolution

While it feels like we’re back to a pre-pandemic sense of normal, COVID continues to be an evolving virus, mutating into...

A Ready-Made Solution for Accelerating RSV Research

With the surge in RSV cases that plagued our nation’s children at record levels this fall and over 100,000 young childre...

Lessons Learned from COVID-19 Clinical Trials

The challenges of the COVID-19 pandemic did bring about some positive impact, accelerating the application of real-world...

Subscribe to the HealthVerity blog

Contact us